Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel [NA]
This clinical trial evaluates whether 68Ga-DOTATOC PET/CT-enterography can detect the primary lesion in small bowel neuroendocrine tumors, a…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors
An ongoing observational cohort study by Hospices Civils de Lyon examining the development and progression of carcinoid heart disease in adu…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study [Phase 2]
This clinical trial update notes a Phase 2 study evaluating metronomic temozolomide in unfit patients with advanced neuroendocrine tumors (N…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors [Phase 1, Phase 2]
Open-label, single-center Phase 1/2 clinical trial evaluating combining surufatinib with temozolomide and S-1 as first-line therapy for adva…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
A recruiting clinical trial in China aims to study protein molecular characteristics and prognosis of cervical neuroendocrine tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. [Phase 2]
Phase II trial evaluating dendritic cells loaded with autologous tumor homogenate as adjuvant vaccination in resected stage IV rare cancers;…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor [Phase 2]
A Phase II clinical trial is evaluating Leflunomide for neuroendocrine tumors associated with multiple endocrine neoplasia type 1; the study…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
A Phase 2 clinical trial is evaluating nab-sirolimus in patients with well-differentiated neuroendocrine tumors of the gastrointestinal trac…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 study is evaluating daily 5 mg versus 10 mg everolimus in patients with neuroendocrine tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating simultaneous hyperpolarized [1-13C]pyruvate and 18F-FDG PET/MRS in cancer patients is currently enrollin…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Observational Study on GEP-and Pulm-NET Treated at FPG
An observational clinical trial update describes a study of gastroenteropancreatic and pulmonary neuroendocrine tumors treated at Fondazione…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study
Feasibility study examining the use of video consultations for follow-up care in patients with neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients
Clinical trial update on a multiparametric prognostic and predictive system to classify patients with neuroendocrine neoplasms grade 3 (NET …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Surgical Intervention and the NETest [NA]
Clinical trial update for a surgical intervention study using the NETest in neuroendocrine tumors. Sponsor Wren Laboratories LLC indicates t…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: The Management of Neuroendocrine Tumours: A Nutritional Viewpoint.
A completed clinical trial examining the role of a Mediterranean diet in the management of neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors [NA]
This clinical trial update from CHU de Reims evaluates whole-body MRI correlated with spreading sequences for staging metastatic neuroendocr…
-
CLINICAL_TRIALS research · 2014-09-22Clinical Trial Update: A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. [NA]
A clinical trial update describes a study comparing two needle devices for endoscopic ultrasound-guided fine-needle aspiration of solid lesi…
-
CLINICAL_TRIALS research · 2012-09-18Clinical Trial Update: Heart/Mediastinal Ratio Study for Potential Equivalence of Heart/Mediastinal Ratios at One and Two Hours to the Traditional Heart/Mediastinal Ratio Obtained at Four Hours
This clinical trial update examines whether heart/mediastinal ratio measurements at 1 or 2 hours can be equivalent to the traditional 4-hour…
-
CLINICAL_TRIALS research · 2012-04-03Clinical Trial Update: 89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors
A completed clinical trial investigating PET imaging with 89Zr-labeled bevacizumab to visualize neuroendocrine tumors.
-
CLINICAL_TRIALS research · 2011-03-03Clinical Trial Update: Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors [Phase 2]
Phase 2 trial investigating hyperthermia/thermal therapy with chemotherapy for inoperable or metastatic tumors. The listed conditions includ…
-
CLINICAL_TRIALS research · 2010-09-23Clinical Trial Update: Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE)
An update on a neoadjuvant peptide receptor radiotherapy trial using Lutetium-177 before liver transplantation for neuroendocrine tumor live…
-
CLINICAL_TRIALS research · 2010-06-03Clinical Trial Update: ProGRP, CgA, NSE and TUM2-PK in in Patients With Neuroendocrine Tumors
This clinical trial update investigates biomarkers ProGRP, CgA, NSE, and TUM2-PK in patients with neuroendocrine tumors. The current status …
-
CLINICAL_TRIALS research · 2009-02-04Clinical Trial Update: Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
An ongoing Rutgers-sponsored clinical trial investigates MEN1 and SDHD in familial carcinoid tumors, a type of neuroendocrine cancer. The cu…
-
CLINICAL_TRIALS research · 2008-10-15Clinical Trial Update: SPECT/CT in Endocrine and Neuroendocrine Tumors [NA]
Clinical trial update on the use of SPECT/CT imaging in neuroendocrine tumors; the study status has completed.